Adding 150 new jobs, greatly increasing central lab capacity
RESEARCH TRIANGLE PARK, N.C., June 6 /CNW/ -- Quintiles Transnational
Corp. today announced that it plans to build a new office near Edinburgh that
will be the Scotland home for its Product Development business, including
Quintiles Laboratories, and its NovaQuest group. The company also will add
150 jobs in Scotland over the next four years.
The new 112,000-square-foot structure -- which Quintiles could expand to
132,000 square feet -- will be built in Livingston, West Lothian, near
Quintiles' present 36,500-square-foot laboratory. The new building will
provide about 80,000 square feet of space for the laboratory business.
Quintiles' Product Development and NovaQuest personnel occupy about 25,000
square feet in a Bathgate office, and these units also will move into the new
building. Quintiles has 390 employees in the two locations.
"Our lab business is expanding -- globally and in Europe -- because of
our proximity to clinical trial sites and our tight quality control," said
Thomas Wollman, Senior Vice President, Global Central Laboratories. "This new
facility will enhance our level of customer service in the UK and Europe, just
as our new central lab in Mumbai has improved service in India. We will
continue to look for opportunities to strengthen our global central lab
The new structure will be developed and built by the Keith Corporation of
Charlotte, N.C., on the Alba Campus business park in Livingston, about 15
miles from Edinburgh city center. Quintiles will sign a 15-year lease for the
facility. Quintiles is receiving a $2.4 million Regional Selective Assistance
Grant from the Scottish Executive to help offset some of the company's $13
million investment in the new building. Under terms of the grant agreement,
Quintiles has agreed to add 150 jobs over the next four years.
"We want to thank West Lothian Council, the Scottish Executive and
Scottish Enterprise for their support in our project," said Graham Murray,
General Manager, Quintiles Laboratories Europe. "Their assistance,
particularly the Regional Selective Assistance grant, was instrumental in our
decision to expand in Livingston."
Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, financial partnering and commercialization for the
pharmaceutical, biotechnology and healthcare industries. With about 18,000
employees and offices in more than 50 countries, it is focused on providing
customer-centric solutions that are the gold standard of the industry. For
more information, please visit the company's Web site at www.quintiles.com.
For further information:
For further information: Dick Jones, Media Relations, +1-919-998-2091,
email@example.com, or Greg Connors, Investor Relations,
+1-919-998-2000, firstname.lastname@example.org, both of Quintiles Transnational Corp.
Web Site: http://www.quintiles.com